Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.

Comer JE, Escaffre O, Neef N, Brasel T, Juelich TL, Smith JK, Smith J, Kalveram B, Perez DD, Massey S, Zhang L, Freiberg AN.

Viruses. 2019 Feb 3;11(2). pii: E137. doi: 10.3390/v11020137.

2.

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.

Russo AT, Grosenbach DW, Brasel TL, Baker RO, Cawthon AG, Reynolds E, Bailey T, Kuehl PJ, Sugita V, Agans K, Hruby DE.

J Infect Dis. 2018 Sep 22;218(9):1490-1499. doi: 10.1093/infdis/jiy326.

3.

Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, Cheminay C, Volkmann A, Brasel T, Carrion R, Giavedoni LD, Patterson JL, Mire CE, Geisbert TW, Hooper JW, Weijtens M, Hartkoorn-Pasma J, Custers J, Grazia Pau M, Schuitemaker H, Zahn R.

PLoS One. 2018 Apr 24;13(4):e0196546. doi: 10.1371/journal.pone.0196546. eCollection 2018.

4.

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, Cheminay C, Volkmann A, Brasel T, Carrion R, Giavedoni LD, Patterson JL, Mire CE, Geisbert TW, Hooper JW, Weijtens M, Hartkoorn-Pasma J, Custers J, Grazia Pau M, Schuitemaker H, Zahn R.

PLoS One. 2018 Feb 20;13(2):e0192312. doi: 10.1371/journal.pone.0192312. eCollection 2018. Erratum in: PLoS One. 2018 Apr 24;13(4):e0196546.

5.

First vaccine approval under the FDA Animal Rule.

Beasley DWC, Brasel TL, Comer JE.

NPJ Vaccines. 2016 Aug 25;1:16013. doi: 10.1038/npjvaccines.2016.13. eCollection 2016.

6.

Antiviral effect of ranpirnase against Ebola virus.

Hodge T, Draper K, Brasel T, Freiberg A, Squiquera L, Sidransky D, Sulley J, Taxman DJ.

Antiviral Res. 2016 Aug;132:210-8. doi: 10.1016/j.antiviral.2016.06.009. Epub 2016 Jun 25.

PMID:
27350309
7.

Performance evaluation of Puritan® universal transport system (UniTranz-RT™) for preservation and transport of clinical viruses.

Brasel T, Madhusudhan KT, Agans K, Dearen K, Jones SL, Sherwood RL.

J Med Virol. 2015 Oct;87(10):1796-805. doi: 10.1002/jmv.24236. Epub 2015 May 6.

PMID:
26243168
8.

Performance evaluation of two universal transport media designed for preservation and transport of Chlamydiae, Mycoplasma and Ureaplasma.

Jones SL, Madhusudhan KT, Agans K, Dearen K, Knight J, Brasel T, Karamchi M, Sherwood RL.

J Med Microbiol. 2015 Apr;64(Pt 4):469. doi: 10.1099/jmm.0.000056. No abstract available.

PMID:
25878260
9.

Performance evaluation of two microbial transport media designed for preservation and transport of Chlamydiae, Mycoplasma and Ureaplasma.

Jones SL, Madhusudhan KT, Agans K, Dearen K, Knight J, Brasel T, Karamchi M, Sherwood RL.

J Med Microbiol. 2015 Apr;64(Pt 4):382-9. doi: 10.1099/jmm.0.000044. Epub 2015 Feb 24. Erratum in: J Med Microbiol. 2015 Apr;64(Pt 4):469.

PMID:
25713205
10.

Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.

Hutt JA, Lovchik JA, Drysdale M, Sherwood RL, Brasel T, Lipscomb MF, Lyons CR.

Am J Pathol. 2014 Dec;184(12):3205-16. doi: 10.1016/j.ajpath.2014.08.008. Epub 2014 Oct 5.

11.

Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.

Massey S, Yeager LA, Blumentritt CA, Vijayakumar S, Sbrana E, Peterson JW, Brasel T, LeDuc JW, Endsley JJ, Torres AG.

Sci Rep. 2014 Mar 7;4:4305. doi: 10.1038/srep04305.

12.

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.

Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK, Zhang L, Tigabu B, Hill TE, Yun T, Pietzsch C, Furuta Y, Freiberg AN.

PLoS Negl Trop Dis. 2013 Dec 26;7(12):e2614. doi: 10.1371/journal.pntd.0002614. eCollection 2013.

13.

Levofloxacin cures experimental pneumonic plague in African green monkeys.

Layton RC, Mega W, McDonald JD, Brasel TL, Barr EB, Gigliotti AP, Koster F.

PLoS Negl Trop Dis. 2011 Feb 8;5(2):e959. doi: 10.1371/journal.pntd.0000959.

14.

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).

Fellows P, Adamovicz J, Hartings J, Sherwood R, Mega W, Brasel T, Barr E, Holland L, Lin W, Rom A, Blackwelder W, Price J, Morris S, Snow D, Hart MK.

Vaccine. 2010 Nov 16;28(49):7748-56. doi: 10.1016/j.vaccine.2010.09.062. Epub 2010 Oct 15.

PMID:
20920572
15.

Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.

Layton RC, Brasel T, Gigliotti A, Barr E, Storch S, Myers L, Hobbs C, Koster F.

J Med Primatol. 2011 Feb;40(1):6-17. doi: 10.1111/j.1600-0684.2010.00443.x. Epub 2010 Aug 16.

16.

Milestones in progression of primary pneumonic plague in cynomolgus macaques.

Koster F, Perlin DS, Park S, Brasel T, Gigliotti A, Barr E, Myers L, Layton RC, Sherwood R, Lyons CR.

Infect Immun. 2010 Jul;78(7):2946-55. doi: 10.1128/IAI.01296-09. Epub 2010 Apr 12.

17.

Immune response among patients exposed to molds.

Edmondson DA, Barrios CS, Brasel TL, Straus DC, Kurup VP, Fink JN.

Int J Mol Sci. 2009 Dec 21;10(12):5471-84. doi: 10.3390/ijms10125471.

18.

Development of a personal bioaerosol sampler based on a conical cyclone with recirculating liquid film.

Tolchinsky AD, Sigaev VI, Sigaev GI, Varfolomeev AN, Zvyagina EV, Brasel T, Cheng YS.

J Occup Environ Hyg. 2010 Mar;7(3):156-62. doi: 10.1080/15459620903486768. Erratum in: J Occup Environ Hyg. 2011 Sep;8(9):D88.

PMID:
20017057
19.

Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague.

Cornelius CA, Quenee LE, Overheim KA, Koster F, Brasel TL, Elli D, Ciletti NA, Schneewind O.

Infect Immun. 2008 Dec;76(12):5588-97. doi: 10.1128/IAI.00699-08. Epub 2008 Sep 15.

20.

Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.

Zhou Y, Brasel TL, Kracko D, Cheng YS, Ahuja A, Norenberg JP, Kelly HW.

Pharm Dev Technol. 2007;12(4):353-9.

PMID:
17763140

Supplemental Content

Loading ...
Support Center